EUVIMEDEUVIMED entdecken
Crossref

Analyte-induced hindrance in the RCA-assisted CRISPR/Cas12a system for homogeneous protein assays

Guobin Mao, Qiaoyu Li, Ziying Zhang, Wei Huang, Qian Luo, Junbiao Dai, Weiren Huang, Yingxin Ma

Analytica Chimica Acta · 2024

DOI: 10.1016/j.aca.2024.343294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024. Verfasst von Guobin Mao und 7 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Quantitative Engineering Biology, Guangdong Provincial Key Laboratory of Synthetic Genomics and Shenzhen Key Laboratory of Synt…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterogeneous assays, such as enzyme-linked immunosorbent assays, have become indispensable for in vitro diagnostics. However, the simple, sensitive, and accurate detection is limited by their multiple washing and incubation steps, and limited amplification methods. In this study, we design a novel approach utilizing analyte-induced hindrance within the rolling circle amplification (RCA)-assisted CRISPR/Cas12a system for simple and highly sensitive homogenous protein detection. Streptavidin (SA) and digoxin antibody (anti-Dig) are employed as representative detection models. The specific recognition of target proteins using primers modified with small molecules hinders the RCA process, preventing the activation of Cas12a's trans-cleavage activity, thereby leading to a reduction in fluorescence intensity. Our developed platform exhibites exceptional detection performance characterized by high sensitivity, robust specificity, and significant potential for application in complex samples. By expanding the recognition elements, this platform can evolve into a versatile clinical diagnostic tool with universal applicability. In addition, this platform provides a novel direction for quantifying ultralow-concentration disease biomarkers in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNucleic Acid Amplification TechniquesStreptavidinHumansDigoxinCRISPR-Associated ProteinsBacterial ProteinsEndodeoxyribonucleases

Stichwörter der Autor:innen

BiosensingCRISPR/Cas12aHomogeneous assayProtein detectionRCA

Substanzen

StreptavidinCas12a proteinDigoxinCRISPR-Associated ProteinsBacterial ProteinsEndodeoxyribonucleases

Autor:innen und Institutionen

  • CAS Key Laboratory of Quantitative Engineering Biology, Guangdong Provincial Key Laboratory of Synthetic Genomics and Shenzhen Key Laboratory of Synthetic Genomics, Shenzhen Institute of Synthetic Biology, Shenzhen Inst…
  • Department of Biology, Southern University of Science and Technology, Shenzhen, 518055, China.
  • Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.

Zitieren

APA

Mao, G., Li, Q., Zhang, Z., Huang, W., Luo, Q., Dai, J., Huang, W., & Ma, Y. (2024). Analyte-induced hindrance in the RCA-assisted CRISPR/Cas12a system for homogeneous protein assays. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2024.343294

Vancouver

Mao G, Li Q, Zhang Z, Huang W, Luo Q, Dai J, et al. Analyte-induced hindrance in the RCA-assisted CRISPR/Cas12a system for homogeneous protein assays. Analytica Chimica Acta. 2024. doi:10.1016/j.aca.2024.343294

BibTeX
@article{Mao2024,
  author = {Mao, Guobin and Li, Qiaoyu and Zhang, Ziying and Huang, Wei and Luo, Qian and Dai, Junbiao and Huang, Weiren and Ma, Yingxin},
  title = {Analyte-induced hindrance in the RCA-assisted CRISPR/Cas12a system for homogeneous protein assays},
  journal = {Analytica Chimica Acta},
  year = {2024},
  doi = {10.1016/j.aca.2024.343294}
}
Kostenlos starten →